Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4(+) T-lymphocytes (Q39812444)

14 September 2017

title

Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4(+) T-lymphocytes (English)

1 reference

14 September 2017

0 references

1 reference

7

1 reference

14 September 2017

8

1 reference

14 September 2017

Richard R Sprenger

3

0 references

Dave Speijer

object named as

Dave Speijer

9

0 references

Rogier W Sanders

5

object named as

Rogier W Sanders

1 reference

14 September 2017

Martijn J Stax

1

1 reference

14 September 2017

Thijs van Montfort

2

1 reference

14 September 2017

Mark Melchers

4

1 reference

14 September 2017

Elisabeth van Leeuwen

6

1 reference

14 September 2017

William A Paxton

10

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

14 September 2017

1 reference

14 September 2017

volume

391

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

203-211

1 reference

Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Risk factors for HIV-1 seroconversion among young men in northern Thailand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

The expression of free oligosaccharides in human seminal plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

HIV-1/AIDS and the control of other infectious diseases in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Measles virus targets DC-SIGN to enhance dendritic cell infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Langerin is a natural barrier to HIV-1 transmission by Langerhans cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Perils at mucosal front lines for HIV and SIV and their hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Antiviral activity of purified human breast milk mucin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

The inhibition of the Human Immunodeficiency Virus type 1 activity by crude and purified human pregnancy plug mucus and mucins in an inhibition assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Human Cytomegalovirus Binding to DC-SIGN Is Required for Dendritic Cell Infection and Target Cell trans-Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Human cervicovaginal lavage fluid contains an inhibitor of HIV binding to dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Why are proteins O-glycosylated?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

AIDS in Africa: a disaster no longer waiting to happen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Changes in glycosylation of human bile-salt-stimulated lipase during lactation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Mucins in the mucosal barrier to infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Semen-derived amyloid fibrils drastically enhance HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Short mucin 6 alleles are associated with H pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

The activity of candidate virucidal agents, low pH and genital secretions against HIV-1 in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Recent advances in our understanding of receptor binding, viral fusion and cell entry of hepatitis C virus: new targets for the design of antiviral agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

HIV-1 selection by epidermal dendritic cells during transmission across human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

The complete genomic organization of the human MUC6 and MUC2 mucin genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Bile-salt-stimulated lipase and mucins from milk of 'secretor' mothers inhibit the binding of Norwalk virus capsids to their carbohydrate ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Inhibiting sexual transmission of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Potential artefacts in proteome analysis of plasma of Gaucher patients due to protease abnormalities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

DC-SIGN: escape mechanism for pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Specificity of DC-SIGN for mannose- and fucose-containing glycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Variable number tandem repeat polymorphism of the mucin genes located in the complex on 11p15.5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Isolation and Characterization of Human Milk Bile Salt-Activated Lipase C-Tail Fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.011

10.1016/J.VIROL.2009.06.011

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference